“The future of fuel lies in e-fuels, which will be pivotal to the global energy transition.”
Oxford University Innovation celebrates the launch of OXCCU's demonstration plant
Oxford University Innovation celebrates the launch of OXCCU's demonstration plant
The team behind MariTest, a non-invasive test for malaria, are the winners of this year’s Student Entrepreneurship Programme
A new company, MatchBio, founded by Professors Omer Dushek and Anton van der Merwe from the Dunn School of Pathology, is set to revolutionise immunotherapy by enhancing CAR T therapy.
Dr Chris Ballance, co-founder and CEO of quantum computing spinout Oxford Ionics talks about the commercial challenges, successful funding rounds, and future collaborations.
Amber Therapeutics successfully closed Series A funding of $100 million (£80 million) from leading healthcare and technology investors in the US and UK.
Oxford University Innovation recently hosted two landmark events that brought together global investors, leading industry experts and innovative spinouts, showcasing the vibrant ecosystem of collaboration and cutting-edge technology at Oxford.
An Oxford University spinout which supports accurate AI applications using Knowledge & Reasoning has been bought by Samsung Electronics.
Yellowstone Biosciences, a biotechnology spinout, has launched to pioneer new cancer treatments using advanced T-cell therapies based on groundbreaking research from the MRC Weatherall Institute of Molecular Medicine at University of Oxford.
Oxford University Innovation (OUI) will welcome more than 50 investors today for the first ever Deep Tech focused showcase day in Oxford to connect them with spinout companies seeking investment and partnership.
OrganOx Ltd, a leading medical technology company specialising in organ preservation prior to transplantation and the treatment of acute organ failure, has opened its new 18,000 square-foot global headquarters for research, development, and production in Oxford.